Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Balchem Corporation (BCPC)

166.30 -2.40 (-1.42%)
At close: October 28 at 4:00:01 PM EDT
166.30 0.00 (0.00%)
After hours: October 28 at 4:00:49 PM EDT
Trade Balchem on Coinbase
Chart Range Bar
Loading chart for BCPC
  • Previous Close 168.70
  • Open 169.52
  • Bid 120.96 x 200
  • Ask 213.12 x 200
  • Day's Range 165.77 - 169.84
  • 52 Week Range 147.18 - 183.90
  • Volume 168,099
  • Avg. Volume 232,003
  • Market Cap (intraday) 5.301B
  • Beta (5Y Monthly) 0.85
  • PE Ratio (TTM) 31.38
  • EPS (TTM) 5.30
  • Earnings Date Oct 23, 2026
  • Forward Dividend & Yield 0.96 (0.58%)
  • 1y Target Est 208.00
  • Motley Fool Rating Bullish

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

www.balchem.com

1,430

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/28/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BCPC
8.44%
S&P 500 (^GSPC)
13.13%

1-Year Return

BCPC
7.85%
S&P 500 (^GSPC)
12.38%

3-Year Return

BCPC
46.95%
S&P 500 (^GSPC)
88.08%

5-Year Return

BCPC
11.47%
S&P 500 (^GSPC)
68.48%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 290.66M
Earnings 46.73M
Profit Margin 16.08%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
100M
200M
15.0%
15.2%
15.4%
15.6%
15.8%
16.0%

Analyst Insights

View More

Analyst Price Targets

165.00
208.00 Average
166.30 Current
242.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/23/2026
Analyst HC Wainwright & Co.
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 215 -> 210

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.41%

  • Return on Assets (ttm)

    8.53%

  • Return on Equity (ttm)

    13.02%

  • Revenue (ttm)

    1.11B

  • Net Income Avi to Common (ttm)

    170.85M

  • Diluted EPS (ttm)

    5.30

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    66.26M

  • Total Debt/Equity (mrq)

    10.74%

  • Levered Free Cash Flow (ttm)

    139.5M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: